nach oben

Erschienen in:

27.11.2020 | COVID-19 | Leitlinien und Empfehlungen Zur Zeit gratis

Recommendations for treatment of critically ill patients with COVID-19

Version 3 S1 guideline

verfasst von: Prof. Dr. med. S. Kluge, U. Janssens, T. Welte, S. Weber-Carstens, G. Schälte, B. Salzberger, P. Gastmeier, F. Langer, M. Welper, M. Westhoff, M. Pfeifer, F. Hoffmann, B. W. Böttiger, G. Marx, C. Karagiannidis

Erschienen in: Die Anaesthesiologie | Sonderheft 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Since December 2019 a novel coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) has rapidly spread around the world resulting in an acute respiratory illness pandemic. The immense challenges for clinicians and hospitals as well as the strain on many healthcare systems has been unprecedented.

The majority of patients present with mild symptoms of coronavirus disease 2019 (COVID-19); however, 5–8% become critically ill and require intensive care treatment. Acute hypoxemic respiratory failure with severe dyspnea and an increased respiratory rate (>30/min) usually leads to intensive care unit (ICU) admission. At this point bilateral pulmonary infiltrates are typically seen. Patients often develop a severe acute respiratory distress syndrome (ARDS).

So far, remdesivir and dexamethasone have shown clinical effectiveness in severe COVID-19 in hospitalized patients. The main goal of supportive treatment is to ascertain adequate oxygenation. Invasive mechanical ventilation and repeated prone positioning are key elements in treating severely hypoxemic COVID-19 patients.

Strict adherence to basic infection control measures (including hand hygiene) and correct use of personal protection equipment (PPE) are essential in the care of patients. Procedures that lead to formation of aerosols should be carried out with utmost precaution and preparation.

Robert Koch Institut (2020) Hinweise zur Testung von Patienten auf Infektion mit dem neuartigen Coronavirus SARS-CoV‑2. https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Vorl_Testung_nCoV. Accessed 21 July 2020

Robert Koch Institut (2020) SARS-CoV‑2 Steckbrief zur Coronavirus-Krankheit-2019 (COVID-19). https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Steckbrief.html#doc13776792bodyText15. Accessed 21 July 2020

Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A et al (2020) Baseline characteristics and outcomes of 1591 patients infected with SARS-coV‑2 admitted to ICus of the Lombardy region, Italy. JAMA 323(16):1574–1581PubMedPubMedCentral

Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM et al (2020) Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J 55(5):2000547PubMedPubMedCentral

Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM et al (2020) Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. https://doi.org/10.1016/S0140-6736(20)31189-2CrossRefPubMedPubMedCentral

Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L et al (2020) Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study. BMJ 369:m1985PubMedPubMedCentral

Wu Z, McGoogan JM (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA 323(13):1239–1242. https://doi.org/10.1001/jama.2020.2648CrossRefPubMed

Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X et al (2020) CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology 295(1):202–207. https://doi.org/10.1148/radiol.2020200230CrossRefPubMed

Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW et al (2020) Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 323(20):2052–2059. https://doi.org/10.1001/jama.2020.6775CrossRefPubMedPubMedCentral

10.

Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H et al (2020) Clinical course and outcomes of critically ill patients with SARS-CoV‑2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. https://doi.org/10.1016/S2213-2600(20)30079-5CrossRefPubMedPubMedCentral

11.

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. https://doi.org/10.1056/NEJMoa2002032CrossRefPubMedPubMedCentral

12.

Antoch G, Urbach H, Mentzel HJ, Reimer P, Weber W, Wujciak D (2020) SARS-CoV2/COVID-19: Empfehlungen für die Radiologische Versorgung – Eine Stellungnahme der Deutschen Röntgengesellschaft (DRG), der Deutschen Gesellschaft für Neuroradiologie (DGNR), der Gesellschaft für Pädiatrische Radiologie (GPR), der Deutschen Gesellschaft für Interventionelle Radiologie (DeGIR), des Berufsverbands der Neuroradiologen (BDNR) und des Berufsverbands der Radiologen (BDR). Rofo 192(5):418–421PubMed

13.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. https://doi.org/10.1016/S0140-6736(20)30183-5CrossRefPubMedPubMedCentral

14.

Liao X, Wang B, Kang Y (2020) Novel coronavirus infection during the 2019–2020 epidemic: preparing intensive care units-the experience in Sichuan Province, China. Intensive Care Med 46(2):357–360PubMedPubMedCentral

15.

Robert Koch Institut (2020) Empfehlungen des Robert Koch-Institutes zu Hygienemaßnahmen im Rahmen der Behandlung von Patienten mit einer Infektion durch SARS-CoV‑2. https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Hygiene.html. Accessed 21 July 2020

16.

Pfeifer M, Ewig S, Voshaar T, Randerath W, Bauer T, Geiseler J et al (2020) Positionspapier zur praktischen Umsetzung der apparativen Differenzialtherapie der akuten respiratorischen Insuffizienz bei COVID-19. Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin e. V. (DGP). Pneumologie. https://doi.org/10.1055/a-1157-9976CrossRefPubMedPubMedCentral

17.

Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E et al (2020) Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med 46(5):854–887PubMedPubMedCentral

18.

WHO (2020) Clinical management of COVID-19. https://www.who.int/publications/i/item/clinical-management-of-covid-19. Accessed 21 July 2020

19.

Rochwerg B, Granton D, Wang DX, Helviz Y, Einav S, Frat JP et al (2019) High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis. Intensive Care Med 45(5):563–572PubMed

20.

Westhoff M, Schonhofer B, Neumann P, Bickenbach J, Barchfeld T, Becker H et al (2015) Nicht-invasive Beatmung als Therapie der akuten respiratorischen Insuffizienz. S3-Leitlinie herausgegeben von der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. Pneumologie 69(12):719–756PubMed

21.

Rochwerg B, Brochard L, Elliott MW, Hess D, Hill NS, Nava S et al (2017) Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J. https://doi.org/10.1183/13993003.02426-2016CrossRefPubMed

22.

Bellani G, Laffey JG, Pham T, Madotto F, Fan E, Brochard L et al (2017) Noninvasive ventilation of patients with acute respiratory distress syndrome. Insights from the LUNG SAFE study. Am J Respir Crit Care Med 195(1):67–77PubMed

23.

Carteaux G, Millán-Guilarte T, De Prost N, Razazi K, Abid S, Thille AW et al (2016) Failure of noninvasive ventilation for de novo acute hypoxemic respiratory failure: role of tidal volume. Crit Care Med 44(2):282–290PubMed

24.

Cabrini L, Landoni G, Zangrillo A (2020) Minimise nosocomial spread of 2019-nCoV when treating acute respiratory failure. Lancet 395(10225):685PubMedPubMedCentral

25.

Fowler RA, Guest CB, Lapinsky SE, Sibbald WJ, Louie M, Tang P et al (2004) Transmission of severe acute respiratory syndrome during intubation and mechanical ventilation. Am J Respir Crit Care Med 169(11):1198–1202PubMed

26.

Schwarz K, Biller H, Windt H, Koch W, Hohlfeld JM (2015) Characterization of exhaled particles from the human lungs in airway obstruction. J Aerosol Med Pulm Drug Deliv 28(1):52–58PubMed

27.

Simonds AK, Hanak A, Chatwin M, Morrell M, Hall A, Parker KH et al (2010) Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy, nebuliser treatment and chest physiotherapy in clinical practice: implications for management of pandemic influenza and other airborne infections. Health Technol Assess 14(46):131–172PubMed

28.

Hui DS, Chow BK, Lo T, Tsang OTY, Ko FW, Ng SS et al (2019) Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks. Eur Respir J 53(4):1802339. https://doi.org/10.1183/13993003.02339-2018CrossRefPubMed

29.

Hui DS, Chow BK, Ng SS, Chu LCY, Hall SD, Gin T et al (2009) Exhaled air dispersion distances during noninvasive ventilation via different respironics face masks. Chest 136(4):998–1005PubMed

30.

Hui DS, Hall SD, Chan MT, Chow BK, Tsou JY, Joynt GM et al (2006) Noninvasive positive-pressure ventilation: an experimental model to assess air and particle dispersion. Chest 130(3):730–740PubMed

31.

Wachs C, Grensemann J, Kluge S (2020) High-Flow-Sauerstofftherapie – Schritt für Schritt. Dtsch Med Wochenschr 145(10):693–697PubMed

32.

Leonard S, Atwood CW Jr., Walsh BK, DeBellis RJ, Dungan GC, Strasser W et al (2020) Preliminary findings on control of dispersion of aerosols and droplets during high-velocity nasal insufflation therapy using a simple surgical mask: implications for high-flow nasal cannula. Chest 158(3):1046–1049. https://doi.org/10.1016/j.chest.2020.03.043CrossRefPubMed

33.

Darwiche K, Ross B, Gesierich W, Petermann C, Huebner RH, Grah C et al (2020) Empfehlungen zur Durchführung einer Bronchoskopie in Zeiten der COVID-19-Pandemie. Pneumologie 74(5):260–262PubMedPubMedCentral

34.

Greenland JR, Michelow MD, Wang L, London MJ (2020) COVID-19 infection: implications for perioperative and critical care physicians. Anesthesiology 132(6):1346–1361PubMed

35.

Cook TM, El-Boghdadly K, McGuire B, McNarry AF, Patel A, Higgs A (2020) Consensus guidelines for managing the airway in patients with COVID-19:guidelines from the difficult airway society, the association of Anaesthetists the intensive care society, the faculty of intensive care medicine and the royal college of anaesthetists. Anaesthesia 75(6):785–799PubMedPubMedCentral

36.

Schälte GKF, Didion N, Pirlich N, Bickenbach J, Rehm M et al (2020) Besonderheiten des Atemwegsmanagements bei Patienten mit vermuteter oder gesicherter COVID-19 Erkrankung und bei Patienten ohne Infektion während der Corona-Pandemie. Empfehlungen von DGAI und BDA. Anasth Intensivmed 61:132–136

37.

Caputo KM, Byrick R, Chapman MG, Orser BJ, Orser BA (2006) Intubation of SARS patients: infection and perspectives of healthcare workers. Can J Anaesth 53(2):122–129PubMed

38.

Dalli J, Khan MF, Marsh B, Nolan K, Cahill RA (2020) Evaluating intubation boxes for airway management. Br J Anaesth 125(3):e293–e295PubMed

39.

Begley JL, Lavery KE, Nickson CP, Brewster DJ (2020) The aerosol box for intubation in COVID-19 patients: an in-situ simulation crossover study. Anaesthesia 75(8):1014–1021. https://doi.org/10.1111/anae.15115CrossRefPubMed

40.

Peng PWH, Ho PL, Hota SS (2020) Outbreak of a new coronavirus: what anaesthetists should know. Br J Anaesth 124(5):497–501PubMed

41.

Orser BA (2020) Recommendations for endotracheal intubation of COVID-19 patients. Anesth Analg 130(5):1109–1110PubMedPubMedCentral

42.

Piepho T, Cavus E, Noppens R, Byhahn C, Dörges V, Zwissler B, Timmermann A (2015) S1 Leitlinie: Atemwegsmanagement

43.

AWMF (2017) S3-Leitlinie Invasive Beatmung und Einsatz extrakorporaler Verfahren bei akuter respiratorischer Insuffizienz. https://www.awmf.org. Accessed 4 Dec 2017

44.

Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L et al (2020) COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med 46(6):1099–1102. https://doi.org/10.1007/s00134-020-06033-2CrossRefPubMedPubMedCentral

45.

Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D (2020) COVID-19 does not lead to a “typical” acute respiratory distress syndrome. Am J Respir Crit Care Med 201(10):1299–1300PubMedPubMedCentral

46.

Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F et al (2020) Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 383(2):120–128. https://doi.org/10.1056/NEJMoa2015432CrossRefPubMedPubMedCentral

47.

AWMF (2019) S2k-Leitlinie Prolongiertes Weaning. https://www.awmf.org/leitlinien/detail/ll/020-015.html. Accessed 21 July 2020

48.

McGrath BA, Brenner MJ, Warrillow SJ, Pandian V, Arora A, Cameron TS et al (2020) Tracheostomy in the COVID-19 era: global and multidisciplinary guidance. Lancet Respir Med. https://doi.org/10.1016/S2213-2600(20)30230-7CrossRefPubMedPubMedCentral

49.

Hosokawa K, Nishimura M, Egi M, Vincent JL (2015) Timing of tracheotomy in ICU patients: a systematic review of randomized controlled trials. Crit Care 19:424PubMedPubMedCentral

50.

Griffiths RD, Hall JB (2010) Intensive care unit-acquired weakness. Crit Care Med 38(3):779–787PubMed

51.

Girard TD, Kress JP, Fuchs BD, Thomason JW, Schweickert WD, Pun BT et al (2008) Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (awakening and breathing controlled trial): a randomised controlled trial. Lancet 371(9607):126–134PubMed

52.

Wang R, Pan C, Wang X, Xu F, Jiang S, Li M (2019) The impact of tracheotomy timing in critically ill patients undergoing mechanical ventilation: a meta-analysis of randomized controlled clinical trials with trial sequential analysis. Heart Lung 48(1):46–54PubMed

53.

Elkbuli A, Narvel RI, Spano PJ 2nd, Polcz V, Casin A, Hai S et al (2019) Early versus late tracheostomy: is there an outcome difference? Am Surg 85(4):370–375PubMed

54.

Shao F, Xu S, Ma X, Xu Z, Lyu J, Ng M et al (2020) In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China. Resuscitation 151:18–23PubMedPubMedCentral

55.

Deutscher Rat für Wiederbelebung – German Resuscitation Council (GRC) e.V. (2020) Empfehlungen des International Liaison Committee on Resuscitation (ILCOR), des Europäischen Rates für Wiederbelebung (ERC) und des Deutschen Rates für Wiederbelebung/German Resuscitation Council (ERC) zur CPR bei Patienten mit COVID-19. https://www.grc-org.de/ueber-uns/aktuelles. Accessed 21 July 2020

56.

Böttiger BW, Wetsch WA (2019) Pulmonary embolism cardiac arrest: thrombolysis during cardiopulmonary resuscitation and improved survival. Chest 156(6):1035–1036PubMed

57.

Wichmann D, Sperhake JP, Lütgehetmann M, Steurer S, Edler C, Heinemann A et al (2020) Autopsy findings and venous thromboembolism in patients with COVID-19. Ann Intern Med. https://doi.org/10.7326/M20-2003CrossRefPubMedPubMedCentral

58.

Langer F, Kluge S, Klamroth R, Oldenburg J (2020) Coagulopathy in COVID-19 and its implication for safe and efficacious thromboprophylaxis. Hamostaseologie 40(3):264–269. https://doi.org/10.1055/a-1178-3551CrossRefPubMedPubMedCentral

59.

Paranjpe I, Fuster V, Lala A, Russak A, Glicksberg BS, Levin MA et al (2020) Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19. J Am Coll Cardiol 76(1):122–124. https://doi.org/10.1016/j.jacc.2020.05.001CrossRefPubMedPubMedCentral

60.

Connors JM, Levy JH (2020) COVID-19 and its implications for thrombosis and anticoagulation. Blood 135(23):2033–2040. https://doi.org/10.1182/blood.2020006000CrossRefPubMed

61.

Fogarty H, Townsend L, Ni Cheallaigh C, Bergin C, Martin-Loeches I, Browne P et al (2020) COVID19 coagulopathy in Caucasian patients. Br J Haematol 189(6):1044–1049. https://doi.org/10.1111/bjh.16749CrossRefPubMed

62.

Brunkhorst FM, Weigand MA, Pletz M, Gastmeier P, Lemmen SW, Meier-Hellmann A et al (2020) S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge – Langfassung. Med Klin Intensivmed Notfmed 115(2):37–109PubMed

63.

Borba MGS, Val FFA, Sampaio VS, Alexandre MAA, Melo GC, Brito M et al (2020) Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-coV-2) infection: a randomized clinical trial. JAMA Netw Open 3(4):e208857PubMed

64.

Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M et al (2020) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 30(3):269–271PubMedPubMedCentral

65.

Geleris J, Sun Y, Platt J, Zucker J, Baldwin M, Hripcsak G et al (2020) Observational study of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med 382(25):2411–2418PubMed

66.

Chen Z, Hu J, Zhang Z et al (2020) Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial. medRxiV. https://doi.org/10.1101/2020.03.22.20040758CrossRefPubMedPubMedCentral

67.

Hung IF, Lung KC, Tso EY, Liu R, Chung TW, Chu MY et al (2020) Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet. https://doi.org/10.1016/S0140-6736(20)31042-4CrossRefPubMedPubMedCentral

68.

Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G et al (2020) A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 382(19):1787–1799PubMed

69.

Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC et al (2020) Remdesivir for the treatment of Covid-19—preliminary report. N Engl J Med. https://doi.org/10.1056/NEJMoa2007764CrossRefPubMedPubMedCentral

70.

Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y et al (2020) Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 395(10236):1569–1578PubMedPubMedCentral

71.

Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L et al (2020) Dexamethasone in hospitalized patients with Covid-19—preliminary report. N Engl J Med. https://doi.org/10.1056/NEJMoa2021436CrossRefPubMedPubMedCentral

72.

Colaneri M, Bogliolo L, Valsecchi P, Sacchi P, Zuccaro V, Brandolino F et al (2020) Tocilizumab for treatment of severe COVID-19 patients: preliminary results from SMAtteo COvid19 REgistry (SMACORE). Microorganisms 8(5):695. https://doi.org/10.3390/microorganisms8050695CrossRefPubMedCentral

73.

Luo P, Liu Y, Qiu L, Liu X, Liu D, Li J (2020) Tocilizumab treatment in COVID-19: a single center experience. J Med Virol. https://doi.org/10.1002/jmv.25801CrossRefPubMedPubMedCentral

74.

Cavalli G, De Luca G, Campochiaro C et al (2020) Interleukin‑1 blockade with high-dose anakinrain patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol. https://doi.org/10.1016/S2665-9913(20)30127-2CrossRefPubMedPubMedCentral

75.

Valk SJ, Piechotta V, Chai KL, Doree C, Monsef I, Wood EM et al (2020) Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD013600CrossRefPubMedPubMedCentral

76.

Li L, Zhang W, Hu Y, Tong X, Zheng S, Yang J et al (2020) Effect of convalescent plasmatherapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial. JAMA. https://doi.org/10.1001/jama.2020.10044CrossRefPubMedPubMedCentral

77.

University of Liverpool (2020) COVID-19 drug interactions. http://www.covid19-druginteractions.org. Accessed 21 July 2020

78.

Gudbjartsson DF, Helgason A, Jonsson H, Magnusson OT, Melsted P, Norddahl GL et al (2020) Spread of SARS-CoV‑2 in the Icelandic population. N Engl J Med 382(24):2302–2315PubMed

79.

Patel NA (2020) Pediatric COVID-19: systematic review of the literature. Am J Otolaryngol 41(5):102573PubMedPubMedCentral

80.

Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z et al (2020) Epidemiology of COVID-19 among children in China. Pediatrics 145(6):e20200702. https://doi.org/10.1542/peds.2020-0702CrossRefPubMed

81.

Tagarro A, Epalza C, Santos M, Sanz-Santaeufemia FJ, Otheo E, Moraleda C et al (2020) Screening and severity of coronavirus disease 2019 (COVID-19) in children in Madrid, Spain. JAMA Pediatr. https://doi.org/10.1001/jamapediatrics.2020.1346CrossRefPubMedPubMedCentral

82.

Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P et al (2020) Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-coV‑2. JAMA 324(3):259–269. https://doi.org/10.1001/jama.2020.10369CrossRefPubMedPubMedCentral

83.

Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P (2020) Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 395(10237):1607–1608PubMedPubMedCentral

84.

Ramcharan T, Nolan O, Lai CY, Prabhu N, Krishnamurthy R, Richter AG et al (2020) Paediatric inflammatory multisystem syndrome: temporally associated with SARS-coV‑2 (PIMS-TS): cardiac features, management and short-term outcomes at aUK tertiary paediatric hospital. Pediatr Cardiol. https://doi.org/10.1007/s00246-020-02391-2CrossRefPubMedPubMedCentral

85.

Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M et al (2020) An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV‑2 epidemic: an observational cohort study. Lancet 395(10239):1771–1778PubMedPubMedCentral

86.

Janssens U, Burchardi N, Duttge G, Erchinger R, Gretenkort P, Mohr M et al (2012) Therapiezieländerung und Therapiebegrenzung in der Intensivmedizin. Dtsch Interdiszip Ver Intensiv Notf Med 3:103–107

87.

Deutsche Gesellschaft für Palliativmedizin (2020) Stellungnahmen 2020. https://www.dgpalliativmedizin.de/category/178-stellungnahmen-2020.html. Accessed 21 July 2020

88.

Dutzmann J, Hartog C, Janssens U, Jöbges S, Knochel K, Marckmann M et al (2020) Entscheidungen über die Zuteilung intensivmedizinischer Ressourcen im Kontext der COVID-19-Pandemie. https://www.divi.de/register/aktuelle-informationen. Accessed 21 July 2020

Titel: Recommendations for treatment of critically ill patients with COVID-19
Version 3 S1 guideline
verfasst von: Prof. Dr. med. S. Kluge
U. Janssens
T. Welte
S. Weber-Carstens
G. Schälte
B. Salzberger
P. Gastmeier
F. Langer
M. Welper
M. Westhoff
M. Pfeifer
F. Hoffmann
B. W. Böttiger
G. Marx
C. Karagiannidis
Publikationsdatum: 27.11.2020
Verlag: Springer Medizin
Schlagwort: COVID-19
Erschienen in: Die Anaesthesiologie / Ausgabe Sonderheft 1/2021
Print ISSN: 2731-6858
Elektronische ISSN: 2731-6866
DOI: https://doi.org/10.1007/s00101-020-00879-3

Neu im Fachgebiet AINS

23.04.2024 | Appendizitis | Nachrichten

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Recommendations for treatment of critically ill patients with COVID-19

Version 3 S1 guideline

Abstract

Neu im Fachgebiet AINS

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Update AINS

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 1/2021

Effects of Apolipoprotein Ε ε4 allele on early postoperative cognitive dysfunction after anesthesia

Combined spinal epidural anesthesia in obese parturients undergoing cesarean surgery

Why erector spinae plane block is more efficient than midtransverse process to pleura block in lumbar spinal surgery

Implementation of anesthesia quality indicators in Germany

Erratum zu: Therapie der sepsisinduzierten Koagulopathie. Ergebnisse einer deutschlandweiten Umfrage auf Intensivstationen

Staff and organizational requirements for pain services in hospitals

Neu im Fachgebiet AINS

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Update AINS